Updates are available Correction dated 2023-04-01
Click to view Correction: https://doi.org/10.1007/s13365-023-01128-0
-
Authors
Johnston, Carrie D. https://orcid.org/0000-0002-2828-8718
de Menezes, Erika G. Marques
Bowler, Scott
Siegler, Eugenia L.
Friday, Courtney
Norris, Philip J.
Rice, Michelle C.
Choi, Mary E.
Glesby, Marshall J.
Ndhlovu, Lishomwa C.
-
Funding
Funding for this research was provided by:
National Institute on Aging (K23AG072960)
National Center for Advancing Translational Sciences (UL1TR000457)
National Institute of Neurological Disorders and Stroke (R01 NS117458)
National Institute of Neurological Disorders and Stroke (R21NS106970)
Weill Cornell Medical College
Gilead Sciences
- License Information
-
More Information
Article History
Received: 21 November 2022
Revised: 23 January 2023
Accepted: 15 February 2023
First Online: 18 March 2023
Change Date: 1 April 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s13365-023-01128-0
Declarations
:
: C.D.J served as a consultant for TheraTechnologies. M.J.G. reports research support to his institution (Weill Cornell Medicine) from Gilead Sciences and Regeneron, has served as a consultant to Enzychem, Regeneron, ReAlta Life Sciences, and Sobi, and receives royalties from Springer and UpToDate. L.C.N. reports grants from the NIH and has received consulting fees from work as a scientific advisor for AbbVie, ViiV Healthcare, and Cytodyn and for service on the Board of Directors of CytoDyn, all for work outside of the submitted work. E.G.M., S.B., and P.J.N. have no conflicts to report.
